198 related articles for article (PubMed ID: 24786638)
21. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK
Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674
[TBL] [Abstract][Full Text] [Related]
22. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.
Golubovskaya VM; Figel S; Ho BT; Johnson CP; Yemma M; Huang G; Zheng M; Nyberg C; Magis A; Ostrov DA; Gelman IH; Cance WG
Carcinogenesis; 2012 May; 33(5):1004-13. PubMed ID: 22402131
[TBL] [Abstract][Full Text] [Related]
23. The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.
Houshmandi SS; Emnett RJ; Giovannini M; Gutmann DH
Mol Cell Biol; 2009 Mar; 29(6):1472-86. PubMed ID: 19103750
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.
Stokes JB; Adair SJ; Slack-Davis JK; Walters DM; Tilghman RW; Hershey ED; Lowrey B; Thomas KS; Bouton AH; Hwang RF; Stelow EB; Parsons JT; Bauer TW
Mol Cancer Ther; 2011 Nov; 10(11):2135-45. PubMed ID: 21903606
[TBL] [Abstract][Full Text] [Related]
25. FAK inhibitor PF-431396 suppresses IgE-mediated mast cell activation and allergic inflammation in mice.
Chen JJ; Zhang LN; Wang HN; Xie CC; Li WY; Gao P; Hu WZ; Zhao ZF; Ji K
Biochem Pharmacol; 2021 Oct; 192():114722. PubMed ID: 34384759
[TBL] [Abstract][Full Text] [Related]
26. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
[TBL] [Abstract][Full Text] [Related]
27. Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.
Troutman S; Moleirinho S; Kota S; Nettles K; Fallahi M; Johnson GL; Kissil JL
Oncotarget; 2016 Aug; 7(34):54515-54525. PubMed ID: 27363027
[TBL] [Abstract][Full Text] [Related]
28. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na
Liu C; Yu M; Li Y; Wang H; Xu C; Zhang X; Li M; Guo H; Ma D; Guo X
Cancer Med; 2021 Jan; 10(1):337-349. PubMed ID: 33280262
[TBL] [Abstract][Full Text] [Related]
29. Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.
López-Lago MA; Okada T; Murillo MM; Socci N; Giancotti FG
Mol Cell Biol; 2009 Aug; 29(15):4235-49. PubMed ID: 19451229
[TBL] [Abstract][Full Text] [Related]
30. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
Al-Ghabkari A; Qasrawi DO; Alshehri M; Narendran A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1461-1469. PubMed ID: 31006845
[TBL] [Abstract][Full Text] [Related]
31. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
[TBL] [Abstract][Full Text] [Related]
33. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.
Sood AK; Coffin JE; Schneider GB; Fletcher MS; DeYoung BR; Gruman LM; Gershenson DM; Schaller MD; Hendrix MJ
Am J Pathol; 2004 Oct; 165(4):1087-95. PubMed ID: 15466376
[TBL] [Abstract][Full Text] [Related]
34. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
35. Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
Ou WB; Lu M; Eilers G; Li H; Ding J; Meng X; Wu Y; He Q; Sheng Q; Zhou HM; Fletcher JA
Br J Cancer; 2016 Nov; 115(10):1253-1263. PubMed ID: 27736841
[TBL] [Abstract][Full Text] [Related]
36. Elucidating the role of the kinase activity of endothelial cell focal adhesion kinase in angiocrine signalling and tumour growth.
Newport E; Pedrosa AR; Lees D; Dukinfield M; Carter E; Gomez-Escudero J; Casado P; Rajeeve V; Reynolds LE; R Cutillas P; Duffy SW; De Luxán Delgado B; Hodivala-Dilke K
J Pathol; 2022 Feb; 256(2):235-247. PubMed ID: 34743335
[TBL] [Abstract][Full Text] [Related]
37. FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics.
O'Brien S; Golubovskaya VM; Conroy J; Liu S; Wang D; Liu B; Cance WG
Oncotarget; 2014 Sep; 5(17):7945-59. PubMed ID: 25277206
[TBL] [Abstract][Full Text] [Related]
38. Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.
Novetsky AP; Thompson DM; Zighelboim I; Thaker PH; Powell MA; Mutch DG; Goodfellow PJ
Int J Gynecol Cancer; 2013 Feb; 23(2):361-6. PubMed ID: 23295942
[TBL] [Abstract][Full Text] [Related]
39. Merlin is a negative regulator of human melanoma growth.
Murray LB; Lau YK; Yu Q
PLoS One; 2012; 7(8):e43295. PubMed ID: 22912849
[TBL] [Abstract][Full Text] [Related]
40. Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors.
Levy A; Alhazzani K; Dondapati P; Alaseem A; Cheema K; Thallapureddy K; Kaur P; Alobid S; Rathinavelu A
Curr Cancer Drug Targets; 2019; 19(3):179-188. PubMed ID: 29984656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
